###### Join the Nation's Conversation

To find out more about Facebook commenting please read the Conversation Guidelines and FAQs

###### Share This Story!

Let friends in your social network know what you are reading about

Share Twitter Google+LinkedIn

#### FDA OKs radiation-based prostate cancer drug

#### The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.

Post to Facebook

#### Posted!

A link has been posted to your Facebook feed.

#### Tweeted!

A tweet has been posted to your Twitter account.

#### Sent!

A link has been sent to your friend's email address.

### This story is part of Health and Wellness

National parks dishing up healthier fare this summer
Views of homosexuality vary across nations, report says
Most parents not worried about children's screen time

# FDA OKs radiation-based prostate cancer drug

2:49 p.m. EDT May 15, 2013

### Story Highlights

- Bayer Pharmaceuticals makes Xofigo
- Drug approved to treat advanced prostate cancer
- Side effects include nausea and diarrhea

WASHINGTON (AP) — The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.

The FDA said Wednesday it approved the drug, Xofigo from Bayer Pharmaceuticals, for men whose cancer has grown into bone tumors even after receiving medication or surgery to lower testosterone. The hormone spurs growth of prostate tumors.

Regulators approved Xofigo based on a study of 809 men with advanced prostate cancer who received the drug or placebo. Patients taking Xofigo typically lived 14 months compared to 11.2 months for those taking placebo.

Xofigo's side effects include nausea and diarrhea.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

###### USA NOW

##### Things to know about notorious Whitey Bulger | USA NOW video

##### Jun 04, 2013

### More Stories:

### This story is part of Health and Wellness

National parks dishing up healthier fare this summer
Views of homosexuality vary across nations, report says
Most parents not worried about children's screen time
{ "js_modules": [], "assetid": "2162723", "aws": "news/national", "aws_id": "news_national", "blogname": "", "byline":"", "contenttype": "story pages ", "seotitle": "Prostate-cancer-drug", "seotitletag": "FDA OKs radiation-based prostate cancer drug", "ssts": "news/nation", "taxonomykeywords":"U.S. Food and Drug Administration,Health and Wellness", "templatename": "stories/default", "topic":"health-and-wellness", "videoincluded":"no", "basePageType":"story" }